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 Chapter 27 
 The Simulator of the Human Intestinal 
Microbial Ecosystem (SHIME ® ) 
 Tom  Van de Wiele ,  Pieter  Van den  Abbeele ,  Wendy  Ossieur ,  Sam  Possemiers , 
and  Massimo  Marzorati 
 Abstract  This chapter provides a general explanation of the Simulator of the Human 
Intestinal Microbial Ecosystem (SHIME ® ). The SHIME is one of the few gut models 
that mimics the entire gastrointestinal tract incorporating stomach, small intestine 
and different colon regions. After a general description of the model’s development 
history and an overview of the specifi c features that distinguish SHIME from other 
gut models, we will give some insight in the general protocol of running SHIME 
experiments. However, with the SHIME being a highly fl exible experimental setup, 
we also dedicate some part of this chapter discussing the modifi cations that can be 
performed, especially with respect to simulation of the mucosal (micro-)environment 
and interaction with host cells. 
 Keywords  Multi-stage gut model •  Colon microbiome •  Mechanistic •  Microbial 
adaptation 
27.1  Description of SHIME ® 
 ‘SHIME’ is an acronym for the Simulator of the Human Intestinal Microbial 
Ecosystem and since 2010, the name has been jointly registered by ProDigest and 
Ghent University. This paragraph primarily describes the conventional experimental 
setup of the SHIME ® system. Yet, because of its modular setup, the SHIME is 
highly fl exible and it can be technically modifi ed to target digestive conditions of 
interest: this will be briefl y discussed further down this chapter. 
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27.1.1  History of the Model 
 The Simulator of the Human Intestinal Microbial Ecosystem (SHIME) is a multi- 
compartment dynamic simulator of the human gut developed in 1993 (Molly et al. 
 1993 ). The development of multi-compartment simulators of (parts of) the human gut 
originated from the awareness that fecal microbiota signifi cantly differ from the 
in vivo colon microbiota in terms of community composition and metabolic activity. 
While inoculation of fecal microbiota into single-stage chemostats was a fi rst attempt 
to mimic colon conditions, it was only useful for limited periods of time since envi-
ronmental parameters such as pH, redox potential, available nutrients and microbial 
population dynamics constantly change. In order to maintain the inoculated intestinal 
microbiota over a longer timeframe, semi-continuous fermenters were developed 
where the intermittent supplementation of nutritional medium and the removal of 
microbial suspension could be simulated (Miller and Wolin  1981 ). While the latter 
systems typically make use of one single fermenter, the colon is a very heterogeneous 
region with clear differences in substrate availability, fermentation activity, microbial 
composition and several environmental conditions. This makes it impossible to 
simulate a representative culture of colon microbiota in one compartment. Several 
multi-compartment reactors were therefore developed to simulate the different condi-
tions of the colon lumen (Macfarlane et al.  1989 ; Miller and Wolin  1981 ), from which 
the SHIME was one of the last in this generation of gut simulators. 
 Technically, the SHIME is an evolution of the simulator of the University of 
Reading introduced by Macfarlane et al. ( 1989 ) and mimics the conditions in the 
ascending, transverse and descending colon regions. The SHIME differentiates from 
the Reading model by incorporation of upper digestive tract conditions, leading to a 
succession of fi ve compartments simulating the upper (stomach, small intestine) and 
the lower (ascending, transverse and descending colon) digestive tract. 
 The entire SHIME reactor operates at 37 °C. It contains double-jacketed glass 
vessels that are connected through peristaltic pumps (Fig.  27.1 ). The fi rst two reactors 
 Fig. 27.1  Schematic representation of the SHIME ® 
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follow a fi ll-and-draw principle adding three times a day a defi ned nutritional medium 
to a gastric compartment, and pancreatic and bile liquid to a small intestine compart-
ment. The medium is composed of complex carbohydrate and protein sources with 
addition of mucins and a mineral and vitamin mix (Molly et al.  1993 ). Upon digestion 
in the gastric and intestine compartments, the slurry is pumped in the ascending colon 
vessel where colon digestion is initiated. The three colon compartments are continu-
ously stirred with constant volume and pH control. Retention times in the upper diges-
tive tract can be modulated by changing the fl ow rates from the gastric and intestine 
compartments, while retention times from the colon compartments are primarily 
modulated through a change in compartment volume. Depending on the human target 
group of interest the retention time may vary from 24 h to 72 h. 
 The pH of the gastric compartment used to work at a fi xed pH of 2.0, yet with the 
advent of a completely computer-controlled SHIME system, specifi c pH profi les 
during gastric and intestine digestion can be established as well. While the small 
intestine compartment typically operates at slightly acidic to neutral conditions, the 
pH of the colon compartments is controlled between 5.6 and 5.9 in the ascending, 
6.1–6.4 in the transverse and 6.6–6.9 in the descending colon. Mixing of the diges-
tive slurry in the respective compartments is obtained with magnetic stir bars. 
The entire SHIME system is kept anaerobic by daily fl ushing the headspace of the 
respective compartments with N 2 gas or a 90/10 % N 2 /CO 2 gas mixture. 
27.1.2  Special Features of the Model 
 The emphasis of the SHIME ® system is primarily put on the simulation of the colon 
microbial community. Because of the inaccessibility of the human colon region to 
take a representative microbial inoculum, the fecal microbiota is chosen as inoculum 
to the colon compartments of the SHIME reactor. The fecal microbiome is signifi -
cantly different from the in vivo colon microbiome, both in terms of composition as 
metabolic activity. Yet, the colon being considered as a plug-fl ow system, the fecal 
microbiome is nothing else than a colon microbiome that has undergone community 
and metabolic shifts during transit from the proximal colon to the rectum. The idea 
of the SHIME system—and other multi-stage colon compartment reactors such as 
the Reading model—is to allow a suitable adaptation period for the fecal microbi-
ome to adapt to the conditions that prevail in the respective colon compartments. 
From an engineering perspective a suitable adaptation time for starting up a reactor 
is around 5–10 times its residence time. Taking the example of a male individual 
with a gut residence time of 48 h and imposing that in the SHIME system, this 
would entail an adaptation time of 10–20 days upon inoculation with the fecal 
microbiota in the colon compartments. We will come back to this stabilization 
aspect in the next paragraph. 
 A second aspect is the choice of inoculum. The SHIME is typically inoculated 
with the fecal microbiome, derived from one individual. There has been or there still 
is a lot of debate on what is the most suitable inoculum for mimicking the human 
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gut microbiome in the most representative way. Some research groups specifi cally 
opt for pooling fecal microbiota from for example ten different individuals (Minekus 
et al.  1999 ), thereby (partly) accounting for the huge interindividual variability that 
exists in microbiome composition and to incorporate properties from different 
microbiomes in order to create an ‘average’ 11th microbiome. Given the enormous 
functional redundancy of the gut microbiome such pooled microbiome will indeed 
take on a normal fermentation profi le which generally not that different from the 
microbial fermentation profi le of a single individual. While such approach may work 
when investigating hydrolysis and fermentation of carbohydrates, it fails to accu-
rately mimic microbial processes that lack this functional redundancy. To exemplify, 
it has become clear that the microbial metabolic potency towards polyphenols such 
as daidzein, isoxanthohumol, catechins and others is highly dependent on an indi-
vidual’s microbiome (van Duynhoven et al.  2011 ). The existence of different 
‘metabotypes’ has therefore even been proposed to distinguish a bioactive metabolite 
producing phenotype from a non-producing phenotype (Bolca et al.  2013 ). The above 
element is the primary reason why a SHIME reactor is inoculated with the fecal 
microbiome from one individual and succeeds in maintaining the microbial meta-
bolic phenotype towards specifi c polyphenols during the in vivo/in vitro transition 
and several weeks after (Decroos et al.  2006 ; Possemiers et al.  2006 ). 
 The choice for individual inocula also appears to be a crucial aspect in recent 
studies where the SHIME was fundamentally optimized to enable colonization of 
the mucosal microbiome (Van den Abbeele et al.  2013 ). This concerns a third spe-
cial feature of the SHIME model. The mucosal microbiome is this part of the gut 
microbial ecosystem that is able to colonize the mucus overlying the gut epithelium. 
Due to its close proximity to host epithelial cells, the mucosal microbiome is thought 
to have an intrinsically higher potency to modulate gut health, and by extension, 
human health (Van den Abbeele et al.  2011 ). The mucosal microbiome was already 
known to fundamentally differ from the luminal microbiome in composition and 
interestingly, presence of important mucosal colonizers such as  Faecalibacterium 
prausnitzii seems to negatively correlate with occurrence (Willing et al.  2009 ) and 
postoperative recurrence of ileal Crohn’s disease (Sokol et al.  2008 ). Given the 
 diffi cult access to the mucosal environment, the development of gut simulators that 
accurately mimic mucosal microbial colonization is considered a strong asset to 
obtain a better understanding of the host-microbe interactome. It is in this philoso-
phy that Van den Abbeele et al. ( 2013 ) decided to optimize the SHIME for mimick-
ing mucosal microbial colonization by incorporation of mucin-covered microcosms. 
The major fi nding of this so-called M-SHIME, or mucosal SHIME, was that colo-
nization of the mucosal environment was characterized by a higher abundance of 
butyrate producing Clostridium clusters IV and XIVa. This phylogenetic group is 
considered crucial for delivering butyrate as primary energy source to colonocytes 
and improves gut barrier function by strengthening the tight junctions. Coming back 
to the importance of individual inocula and avoiding pooled samples, it was also 
demonstrated that the M-SHIME was able to maintain the unique features of an 
individual’s microbiome in terms of its mucosal composition (Van den Abbeele 
et al.  2013 ). 
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 The fourth feature is the fl exibility of the SHIME model and the ease with which 
reactor compartments can be added or left away. This modular setup is useful when 
a placebo-controlled study needs to be conducted, when different prebiotics need to 
be compared (Grootaert et al.  2009 ) or when a microbiome phenotype producing a 
bioactive metabolite is compared with a non-producing phenotype (Possemiers 
et al.  2006 ). Moreover, it is even possible to explore the interindividual variability 
in microbiome behavior upon specifi c treatments by having a common upper diges-
tive tract simulation in the gastric and intestine compartments and subsequently 
split up the system in several parallel colon compartments, each of which are inocu-
lated with the fecal microbiota from separate individuals. 
 A fi fth feature of the SHIME model refers to the possibility of simulating the 
microbiome from different human target groups such as adult vs. infant, healthy vs. 
diseased (e.g. ulcerative colitis patients: Vermeiren et al.  2012 ) as well as the simu-
lation of animal (pig, dog) microbiomes. In each of these specifi c cases, the micro-
bial inocula, residence times of the different gastric compartments, composition of 
the gastric juices, region specifi c pH’s, feed, feeding regimes and body temperatures 
are adapted in the SHIME set-up leading to an accurate and relevant simulation of 
the targeted human or animal host. Finally, other features of the SHIME include the 
gradual emptying of the gastric digest into the intestine compartment, the option of 
running a dynamic pH profi les in the gastric compartment and the possibility of put-
ting a dialysis unit behind the intestine compartment to enable running experiments 
with real food matrices or food constituents that need to undergo predigestion and 
removal of sugar monomers or amino acids and peptides before the digest is trans-
ferred to the colon compartment. 
27.1.3  Stability and Reproducibility of the System 
 As the SHIME ® reactor is inoculated with a fecal microbiome, the latter needs an 
appropriate amount of time to adapt to the prevailing environmental conditions in the 
respective colon compartments. This adaptation process was studied more in detail 
by Possemiers et al. ( 2004 ) who monitored the increasing colonization of microbial 
groups of interest upon inoculation, as well as their metabolic activity. Highly-
abundant groups such as  Bacteroides obtained stable concentrations more easily, at 
10 days, compared to less-abundant groups such as lactobacilli which needed 15 days 
of stabilization. To obtain a stable functionality in terms of short chain fatty acid 
production, an adaptation period of at least 15 days, even approaching 20 days, was 
needed. The length of stabilization obviously relates to the residence time that 
is imposed in the SHIME, but may also depend on the microbiome composition 
as such. 
 As the SHIME is a highly standardized system, and many digestive parameters 
are under control of the operator, it also leads to highly reproducible results. This 
is especially required when different products such as novel prebiotics, candidate 
drug components or new plant extracts, need to be compared with one another. 
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When it is not always possible to run different SHIMEs in parallel, for example 
because of the multitude of test compounds, SHIME experiments may need to be 
repeated. The scientist in charge needs to be cautious to conduct this experiment in 
exactly the same way and with the same inoculum to enable an adequate comparison 
between different compounds. Such reproducibility was previously tested for the 
conventional SHIME (without mucin-coated microcosms) and proven very effective 
in obtaining a reproducible microbial colonization process and accompanied meta-
bolic activity (Van den Abbeele et al.  2010 ). Noteworthy, the authors found a small 
preferential colonization of  Bacteroidetes and  Clostridium cluster IX in the colon 
compartments in comparison with the stool sample. While the overall colonization 
profi le was still representative of the in vivo colonization process, this slight bias has 
been a common observation for several dynamic models that work with luminal 
content only. Van den Abbeele et al. ( 2013 ) succeeded in removing this colonization 
selectivity by incorporating mucin-covered microcosms in the SHIME, thereby 
 creating the M-SHIME or mucosal SHIME. Butyrate producing  Clostridium clusters 
IV and XIVa were found to specifi cally colonize the mucosal environment thereby 
compensating for their lower abundance in the lumen. 
27.1.4  Relevance to Human In Vivo Situation 
 The fi rst validation paper of the conventional SHIME ® setup concerned a study 
from Molly et al. ( 1994 ) where several microbe-associated characteristics were 
defi ned. The authors focused on fermentation profi les of pectin, xylan, arabinoga-
lactan and starch and found these to be consistent with the results from incubations 
of the same products with fecal microbiota from human volunteers (Englyst et al. 
 1987 ). Similarly, an enzymatic profi le focusing on glycosyl hydrolases (galactosi-
dase, glucosidase, xylosidase) was recorded and no differences with the fecal incu-
bations were found. Apart from the comparison with fermentation activity the 
metabolic potency towards sulphasalazin, a prodrug for ulcerative colitis treatment, 
and its conversion to the active compound 5-aminosalicylic acid (5-ASA) was also 
evaluated. Consistent with in vivo literature, no 5-ASA was detected in the gastric 
compartment, while small amounts of 5-ASA were detected in the intestine com-
partment and full sulphasalazin conversion was observed in the colon compartments 
(Peppercorn and Goldman  1972 ). 
 A second validation study discusses the preservation of metabolic phenotypes 
when transferring fecal microbiota from an individual to the in vitro SHIME sys-
tem. Focusing on the microbial conversion of isoxanthohumol to 8- prenylnaringenin 
(8-PN), a metabolite with strong pseudo-estrogenic activity, Possemiers et al. ( 2006 ) 
demonstrated a one-on-one correlation between urinary 8-PN excretion by human 
individuals and their microbiome. Secondly, the microbiome from a 8-PN produc-
ing and non-producing individual could be stably transferred to the SHIME system 
and the metabolic phenotype was adequately preserved. 
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 A third validation study concerns the application of the M-SHIME where both the 
luminal as mucosal microbiome from an individual were simulated in the SHIME 
colon compartment (Van den Abbeele et al.  2013 ). Analyzing the microbiome from 
the luminal and mucosal regions with the HIT-Chip micro-array revealed the largest 
variability in the microbial dataset to originate from the in vivo/in vitro transition 
and difference between the luminal and mucosal environment. Yet, those species 
that account for the unique profi le of an individual’s microbiome were preserved in 
the M-SHIME as well and accounted for 25 % of the variability in the microbial 
dataset. 
27.1.5  Quality in Relation to Other Models 
with the Same Applicability 
 The SHIME ® model is the sole in vitro model that integrates the entire gastrointestinal 
transit into one system. This is interesting to study for example digestibility of 
prebiotic substrates and its subsequent fermentability in the colon or the survival of 
pathogens or probiotics in the upper digestive tract before they reach the colon envi-
ronment. Yet, one must consider that the conventional SHIME system operates 
without an absorption unit: this means that the nutritional medium for the SHIME 
must already be deprived of easily digestible carbohydrates or proteins that would 
normally be absorbed in the intestine. 
 The SHIME is the last of a generation of multi-compartment models that operate 
according to a semi-continuous stirred tank reactors setup. In comparison with the 
Reading model (Macfarlane et al.  1989 ) the SHIME connects the different 
 compartments through peristaltic pumps. In terms of studying the gut microbiome 
over a long timeframe, both models would however be applicable. 
 In general, it must be stressed that the SHIME model has a strong emphasis on 
the ecological aspects of the colon microbiome. This entails that incubation experi-
ments with the SHIME reactor are seldomly short and commonly take several 
weeks. This is put in place to look at the gradual adaptation of the microbiome to 
incoming substrates of interest (e.g. prebiotics or pharmaceuticals) or to evaluate 
the resilience of the microbial community against colonization by a (opportunistic) 
pathogen. Such research, which often necessitates an experimental period of more 
than a week to several weeks, strongly differs from the TIM-2 model, which moni-
tors the microbiome on a shorter timeframe. One could conclude that short term 
experiments are highly suitable for evaluating the immediate metabolic potency of 
a carbohydrate or colonization ability of a microorganism of interest, while long- 
term experiments are primarily suitable to look at the adaptation of the microbial 
ecosystem to changing environmental conditions or inputs. 
 A last strong asset of the SHIME is its extension to M-SHIME—incorporating the 
mucosal microbiota (Van den Abbeele et al.  2013 ). While previous attempts primarily 
focused on the immediate and aspecifi c adhesion potency of gut microorganisms to 
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mucin-covered glass slides, the integration of mucin-covered microcosms that can 
be replaced, to mimic desquamation, has been a breakthrough in the simulation of 
the mucosal microbiome and in the understanding of its dynamics. 
27.2  General Protocol 
 Inoculation of the SHIME ® colon compartments occurs with microbiota that has 
been isolated from fecal material of one individual. In contrast with other gut models, 
we deliberately choose not to work with the microbiome from pooled fecal samples 
from different human volunteers. The artifi cially high microbial diversity in pooled 
inocula creates disturbances in the cross-feeding processes between microorganisms 
that are adapted to one another in each of the separate microbiomes. We therefore 
advise to study interindividual variability through separate experiments. Upon inocu-
lation of the colon compartments with fecal microbiota, the microbiome is given 
time to adapt itself to the prevailing conditions in the ascending, transverse and 
descending colon compartments. 
 A typical SHIME experiment consists of four stages: a stabilization period 
(2 weeks) to allow adaptation of the microbial community to the environmental 
conditions in the respective colon regions; a basal period (2 weeks) in which the 
reactor is operated under nominal conditions and baseline parameters are measured; 
a treatment period (2–4 weeks) where the effect of a specifi c treatment on the gas-
trointestinal microbial community is tested; and a washout period (2 weeks) to 
determine how long the changes induced by the tested substance can still be mea-
sured in the absence of the substance itself. This approach has mainly been used to 
investigate the activity and stability of probiotics and prebiotics during 
 gastrointestinal transfer, the microbial conversion of bioactive food components 
(e.g. phytoestrogens), the metabolism of pharmaceutical components, the effi cacy 
of colonic targeted delivery systems and the conversion and biological (in)activation 
of food and/or ingested environmental contaminants. 
 Shorter-term SHIME experiments are also a possibility. Specifi cally in the 
context of monitoring the initial stages of microbial colonization on the mucosal 
surface, 1-week experiments can be conducted. Distinguishing the mucosal from 
the luminal microbiome, Van den Abbeele et al. ( 2013 ) evaluated the colonization 
process of the microbiome derived from fi ve human volunteers in M-SHIME sys-
tems over a timeframe of 5 days. The presence of mucins seems to play a specifi c 
role in the colonization process. In contrast with mucin surfaces, other contact 
surfaces, such as agar or plastic surfaces, did not result in a distinct colonization 
profi le. Despite the fact that the applied mucins are derived from the porcine 
gut—and hence do not have the exact same composition as human mucins—the 
presence of this fairly similar glycoprotein surface already is an important driver 
in the colonization process. 
 Finally, by choosing the inoculum, tweaking digestive parameters, incorporating 
surface carriers or working with parallel reactor compartments, a SHIME operator 
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is able to mimic the gastrointestinal conditions of a host target group or phenotype 
of interest, to incorporate internal control experiments or experimental replicates 
and to take into account the gastrointestinal colonization by mucosal microbiota. 
27.3  Controls to Test Stability and Performance of the Model 
 As the SHIME ® system can be operated over a longer timeframe, stability of the 
 system is a crucial aspect. Investigating the modulation of the intestinal microbiome 
through certain treatments, also requires proper knowledge of a baseline situation and 
assumption of a stable microbiome. The microbial community composition and 
fermentation activity in the respective colon compartments is therefore closely moni-
tored, especially during reactor startup, to evaluate the reactor’s capacity to create a 
stable microbiome that is still representative for the human in vivo situation. Using 
moving window correlation, Possemiers et al. ( 2004 ) previously introduced a stability 
criterion based on measurements with PCR-DGGE for different microbial groups, 
short chain fatty acids and ammonium. Calculating the correlation between two con-
secutive days along reactor startup, the authors considered a community to be stable 
once 80 % correlation was measured. The remaining 15–20 % variability typically 
originates from normal biological fl uctuations. Overall, community stability is 
reached after about 2 weeks, while functional stability is obtained after 3 weeks. 
This startup phase seems quite long for a conventional SHIME experiment, but it is 
desired when the microbiome from different colon regions is under study and when 
the research question concerns microbial adaptations to applied treatments. Yet, short-
term SHIME experiments can be conducted as well. The mucosal colonization pro-
cess in the M-SHIME occurs quite rapidly—within 5 days—when a clear distinction 
between luminal and mucosal microbiome composition is noted. The preferential 
colonization of butyrate producing clostridia in the mucosal environment is one of the 
characteristic features (Van den Abbeele et al.  2013 ). 
27.4  Read-Out of the System and How This Information 
Can Be Used 
 Assessing fermentation activity is one of the most important SHIME ® read-outs. 
During operation of the SHIME system, short chain fatty acid or ammonia production 
can be preliminary assessed by the amount of NaOH or HCl that is supplemented by 
the pH controllers to maintain proper pH values in the respective colon vessels. 
As the conventional setup of the SHIME system does not have an absorption unit, 
short chain fatty acids (SCFA) do accumulate throughout the distal colon compart-
ments. However, the SCFA concentrations in the SHIME do not lead to values above 
100 mM, which would eventually result in product inhibition of the fermentation 
process. As saccharolytic conditions are more abundant than proteolytic conditions 
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in the proximal colon and vice versa, the operator can still deduce the drop in 
 saccharolytic activity by subtracting the SCFA concentration in the proximal colon 
from the SCFA concentration in the distal colon and thereby obtain the net amount 
of SCFA that are produced in the distal colon. Such strategy has been used before to 
discern the colon regions where specifi c fi bers or oligosaccharides are broken down 
(Grootaert et al.  2009 ). 
 While adaptation of microbiome fermentation profi les to changing nutritional 
conditions is often monitored over several weeks (Grootaert et al.  2009 ), the 
immediate metabolic potency of the colon microbiome towards specifi c com-
pounds of interest can be evaluated within days, e.g. with the onset of isoxantho-
humol conversion into 8-prenylnaringenin (Possemiers et al.  2006 ), or even hours, 
e.g. with the microbial conversion of tea catechins and wine polyphenols (Gross 
et al.  2010 ). 
 Apart from the general fermentation activity and metabolic potency, the SHIME 
is evaluated for the microbiome composition in the respective colon vessels. 
The common approach typically includes establishment of DGGE profi les, either at 
Eubacteria or at group-specifi c level, as a quick screening for evaluating what treat-
ments or what sample times are interesting to study in more detail. This can then be 
complemented by a quantitative analysis with q-PCR or a high-throughput analysis 
at the phylogenetic level with next generation sequencing. One of the important 
read-outs with microbiome fi ngerprints and profi les is the determination of the 
 so- called ‘MRM-parameters’ (microbial resource management) (Marzorati et al. 
 2009 ). These typically contain calculation of richness, evenness and diversity indi-
ces and of microbiome dynamics throughout the study period. Especially evenness 
seems to be a strong indicator of microbiome resilience against invasion by exoge-
nous species (Wittebolle et al.  2009 ). 
 A fi nal read-out consists of an evaluation of host-microbe interactions. Colon 
suspension or the derived intestinal water (supernatant after centrifugation) can be 
brought in indirect or direct contact with host epithelial cells. This allows assessing 
to what extent changes in microbiome composition, microbial metabolites, signal-
ing molecules or antigens have differential effects at the level of the host. This can 
be performed both with epithelial cells (Grootaert et al.  2011 ) as with a combina-
tion of epithelial and immune cells (Possemiers et al.  2013 ). Interestingly, the 
SHIME has recently been coupled to the Host-Microbe Interaction Module (HMI), 
which is a bi-compartmental system containing mucosal microbiota one the one 
side and host cells on the other side of a semi-permeable membrane (Marzorati 
et al.  2014 ). 
27.5  Advantages, Disadvantages and Limitations 
of the System 
 The advantages, disadvantages and limitations of the system are summarized in 
Table  27.1 . 
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